OrbiMed Capital GP VII LLC, 10% Owner at Passage BIO, Inc. (PASG), bought 191,800 shares at $5.52 ($1.1M) on 2022-01-13, disclosed to the SEC on 2022-01-13.
Open-market purchase of $1.1M PASG by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.53 | 8,200 | $45K | 4.2% |
| 2 | $5.65 | 100,000 | $565K | 52.7% |
| 3 | $5.52 | 41,800 | $231K | 21.5% |
| 4 | $5.52 | 41,800 | $231K | 21.5% |
| Total | $5.59 avg | 191,800 | $1.1M | 100% |
| Filing → |
| PASG | SELL | 2024-12-26 | $276K | — | Filing → |
| PASG | SELL | 2024-12-06 | $77K | — | Filing → |
| PASG | SELL | 2024-09-18 | $147K | — | Filing → |